Acquired haemophilia A and concomitant factor XIII consumption
Haemophilia
.
2019 May;25(3):e180-e183.
doi: 10.1111/hae.13690.
Epub 2019 Mar 7.
Authors
Jameel Abdulrehman
1
,
Brett L Houston
2
,
Hina Chaudhry
3
,
Georges-Etienne Rivard
4
,
Jerome M Teitel
5
,
Michelle Sholzberg
3
5
6
Affiliations
1
Department of Medicine, Division of Hematology, University Health Network, Toronto, Ontario, Canada.
2
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
3
Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, Toronto, Ontario, Canada.
4
Division of Hematology/Oncology, Department of Pediatrics, CHU Ste-Justine, Université de Montréal, Montréal, Quebec, Canada.
5
Division of Hematology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
6
Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
PMID:
30843631
DOI:
10.1111/hae.13690
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Aged, 80 and over
Factor XIII / immunology*
Factor XIII / therapeutic use
Female
Hemophilia A / drug therapy
Hemophilia A / immunology*
Humans
Male
Young Adult
Substances
Factor XIII